Login / Signup

Results of an FASD screening tool are associated with neuropsychological and behavioral measures.

Matthew T HylandNatasia S Courchesne-KrakGemma A BernesJeffrey R WozniakKenneth L JonesMiguel CampoEdward P RileySarah N Mattsonnull null
Published in: Alcohol (Hanover, York County, Pa.) (2023)
Results from the FASD-Tree screening tool were associated with neuropsychological and behavioral outcomes. Participants classified as FASD-Positive were more likely to have impairment in all domains tested. These results lend evidence in support of the FASD-Tree as an effective screening tool in clinical settings, providing an efficient and accurate way to identify patients in need of additional evaluation. This article is protected by copyright. All rights reserved.
Keyphrases
  • spectrum disorder
  • end stage renal disease
  • mild cognitive impairment
  • ejection fraction
  • chronic kidney disease
  • high resolution
  • type diabetes
  • metabolic syndrome
  • clinical evaluation